Verfügbarkeit: PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR

PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR:

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Xu, Yinhui 1987- (VerfasserIn)
Format:	Abschlussarbeit Buch
Sprache:	English
Veröffentlicht:	München 2022
Schlagworte:	Krebs > Medizin Pharmakotherapie Immuntherapie Hochschulschrift
Online-Zugang:	kostenfrei kostenfrei
Beschreibung:	101 Seiten Illustrationen, Diagramme
DOI:	10.5282/edoc.30741

Internformat

MARC


LEADER	00000nam a2200000zc 4500
001	BV048588977
003	DE-604
005	00000000000000.0
007	t
008	221201s2022 gw a\|\|\| m\|\|\| 00\|\|\| eng d
015			\|a 22,O12 \|2 dnb
035			\|a (OCoLC)1352881462
035			\|a (DE-599)BVBBV048588977
040			\|a DE-604 \|b ger
041	0		\|a eng
044			\|a gw \|c XA-DE-BY
049			\|a DE-384 \|a DE-473 \|a DE-703 \|a DE-1051 \|a DE-824 \|a DE-29 \|a DE-12 \|a DE-91 \|a DE-19 \|a DE-1049 \|a DE-92 \|a DE-739 \|a DE-898 \|a DE-355 \|a DE-706 \|a DE-20 \|a DE-1102 \|a DE-860 \|a DE-2174
084			\|8 1\p \|a 616.994 \|2 23ksdnb
084			\|8 2\p \|a 610 \|2 23sdnb
100	1		\|a Xu, Yinhui \|d 1987- \|e Verfasser \|0 (DE-588)1274028833 \|4 aut
245	1	0	\|a PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR \|c Yinhui Xu
264		1	\|a München \|c 2022
300			\|a 101 Seiten \|b Illustrationen, Diagramme
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
502			\|b Dissertation \|c München, Ludwig-Maximilians-Universität \|d 2022
650	0	7	\|8 3\p \|a Krebs \|g Medizin \|0 (DE-588)4073781-0 \|2 gnd
650	0	7	\|8 4\p \|a Pharmakotherapie \|0 (DE-588)4076066-2 \|2 gnd
650	0	7	\|8 5\p \|a Immuntherapie \|0 (DE-588)4026640-0 \|2 gnd
655		7	\|0 (DE-588)4113937-9 \|a Hochschulschrift \|2 gnd-content
776	1	8	\|i Erscheint auch als \|n Online-Ausgabe \|o urn:nbn:de:bvb:19-307418 \|o 10.5282/edoc.30741
856	4	1	\|u https://doi.org/10.5282/edoc.30741 \|x Verlag \|z kostenfrei \|3 Volltext
856	4	1	\|u https://nbn-resolving.org/urn:nbn:de:bvb:19-307418 \|x Resolving-System \|z kostenfrei \|3 Volltext
912			\|a ebook
999			\|a oai:aleph.bib-bvb.de:BVB01-033964696
883	0		\|8 1\p \|a emakn \|c 0,18729 \|d 20221122 \|q DE-101 \|u https://d-nb.info/provenance/plan#emakn
883	0		\|8 2\p \|a emasg \|c 0,96670 \|d 20221122 \|q DE-101 \|u https://d-nb.info/provenance/plan#emasg
883	0		\|8 3\p \|a emagnd \|c 0,22248 \|d 20221122 \|q DE-101 \|u https://d-nb.info/provenance/plan#emagnd
883	0		\|8 4\p \|a emagnd \|c 0,19886 \|d 20221122 \|q DE-101 \|u https://d-nb.info/provenance/plan#emagnd
883	0		\|8 5\p \|a emagnd \|c 0,10943 \|d 20221122 \|q DE-101 \|u https://d-nb.info/provenance/plan#emagnd

Datensatz im Suchindex

_version_	1804184625145184256
adam_txt
any_adam_object
any_adam_object_boolean
author	Xu, Yinhui 1987-
author_GND	(DE-588)1274028833
author_facet	Xu, Yinhui 1987-
author_role	aut
author_sort	Xu, Yinhui 1987-
author_variant	y x yx
building	Verbundindex
bvnumber	BV048588977
collection	ebook
ctrlnum	(OCoLC)1352881462 (DE-599)BVBBV048588977
doi_str_mv	10.5282/edoc.30741
format	Thesis Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02105nam a2200457zc 4500</leader><controlfield tag="001">BV048588977</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">221201s2022 gw a\|\|\| m\|\|\| 00\|\|\| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">22,O12</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1352881462</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048588977</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-1051</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-1102</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-2174</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.994</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Xu, Yinhui</subfield><subfield code="d">1987-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1274028833</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR</subfield><subfield code="c">Yinhui Xu</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">München</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">101 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">München, Ludwig-Maximilians-Universität</subfield><subfield code="d">2022</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">3\p</subfield><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">4\p</subfield><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">5\p</subfield><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="776" ind1="1" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="o">urn:nbn:de:bvb:19-307418</subfield><subfield code="o">10.5282/edoc.30741</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://doi.org/10.5282/edoc.30741</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:19-307418</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033964696</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">emakn</subfield><subfield code="c">0,18729</subfield><subfield code="d">20221122</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emakn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">emasg</subfield><subfield code="c">0,96670</subfield><subfield code="d">20221122</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emasg</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">emagnd</subfield><subfield code="c">0,22248</subfield><subfield code="d">20221122</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emagnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">emagnd</subfield><subfield code="c">0,19886</subfield><subfield code="d">20221122</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emagnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">5\p</subfield><subfield code="a">emagnd</subfield><subfield code="c">0,10943</subfield><subfield code="d">20221122</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emagnd</subfield></datafield></record></collection>
genre	(DE-588)4113937-9 Hochschulschrift gnd-content
genre_facet	Hochschulschrift
id	DE-604.BV048588977
illustrated	Illustrated
index_date	2024-07-03T21:07:03Z
indexdate	2024-07-10T09:42:19Z
institution	BVB
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-033964696
oclc_num	1352881462
open_access_boolean	1
owner	DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-20 DE-1102 DE-860 DE-2174
owner_facet	DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-20 DE-1102 DE-860 DE-2174
physical	101 Seiten Illustrationen, Diagramme
psigel	ebook
publishDate	2022
publishDateSearch	2022
publishDateSort	2022
record_format	marc
spelling	Xu, Yinhui 1987- Verfasser (DE-588)1274028833 aut PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR Yinhui Xu München 2022 101 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Dissertation München, Ludwig-Maximilians-Universität 2022 3\p Krebs Medizin (DE-588)4073781-0 gnd 4\p Pharmakotherapie (DE-588)4076066-2 gnd 5\p Immuntherapie (DE-588)4026640-0 gnd (DE-588)4113937-9 Hochschulschrift gnd-content Erscheint auch als Online-Ausgabe urn:nbn:de:bvb:19-307418 10.5282/edoc.30741 https://doi.org/10.5282/edoc.30741 Verlag kostenfrei Volltext https://nbn-resolving.org/urn:nbn:de:bvb:19-307418 Resolving-System kostenfrei Volltext 1\p emakn 0,18729 20221122 DE-101 https://d-nb.info/provenance/plan#emakn 2\p emasg 0,96670 20221122 DE-101 https://d-nb.info/provenance/plan#emasg 3\p emagnd 0,22248 20221122 DE-101 https://d-nb.info/provenance/plan#emagnd 4\p emagnd 0,19886 20221122 DE-101 https://d-nb.info/provenance/plan#emagnd 5\p emagnd 0,10943 20221122 DE-101 https://d-nb.info/provenance/plan#emagnd
spellingShingle	Xu, Yinhui 1987- PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR 3\p Krebs Medizin (DE-588)4073781-0 gnd 4\p Pharmakotherapie (DE-588)4076066-2 gnd 5\p Immuntherapie (DE-588)4026640-0 gnd
subject_GND	(DE-588)4073781-0 (DE-588)4076066-2 (DE-588)4026640-0 (DE-588)4113937-9
title	PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR
title_auth	PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR
title_exact_search	PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR
title_exact_search_txtP	PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR
title_full	PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR Yinhui Xu
title_fullStr	PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR Yinhui Xu
title_full_unstemmed	PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR Yinhui Xu
title_short	PD-L1 enhanced cisplatin resistance in non-small cell lung cancer through PI3K/AKT/mTOR
title_sort	pd l1 enhanced cisplatin resistance in non small cell lung cancer through pi3k akt mtor
topic	3\p Krebs Medizin (DE-588)4073781-0 gnd 4\p Pharmakotherapie (DE-588)4076066-2 gnd 5\p Immuntherapie (DE-588)4026640-0 gnd
topic_facet	Krebs Medizin Pharmakotherapie Immuntherapie Hochschulschrift
url	https://doi.org/10.5282/edoc.30741 https://nbn-resolving.org/urn:nbn:de:bvb:19-307418
work_keys_str_mv	AT xuyinhui pdl1enhancedcisplatinresistanceinnonsmallcelllungcancerthroughpi3kaktmtor

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Volltext öffnen

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge